The loss of touch with reality signaled that she didn’t just have major depression but that she had major depression with ... action to get her treated with electroconvulsive therapy (ECT), the most ...

Prescription digital therapeutics represent the evolving intersection of technology and mental health care – but how do clinicians feel about this new era?

Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt ...

Dr Patricia Ares-Romero and Dr Martin Rosenzweig discuss treatment strategies for TRD, including alternative therapies and explain current barriers within the healthcare system that inhibit access.

A recent study published in Translational Psychiatry found that ketamine, a medication typically used as an anesthetic, may ...

MAGIC’ mushrooms are better at treating depression than conventional medicine, according to a European study.  Depression is ...

Denovo Biopharma receives US FDA fast track designation for its liafensine for treating patients with treatment-resistant depression: San Diego Friday, October 11, 2024, 17:00 Hrs ...

“Our team found that rats given psilocybin were more motivated to explore their environment and perform reward-based tasks. These exciting results show the mechanisms of how psilocybin may work to ...

Scientists are learning more about how psychedelic mushrooms may alter the brain, potentially leading to long-lasting ...

Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for ...

Dr. John Spollen, a psychiatry professor at the UAMS College of Medicine, will discuss psychedelic research including his work with veterans in his upcoming Honors College Mic lecture.

Psilocybin, the psychoactive compound found in magic mushrooms, could revolutionize the treatment of major depressive disorder (MDD), according to a new study that analyzed multiple clinical trials.